Literature DB >> 19666107

Nrf2:INrf2 (Keap1) signaling in oxidative stress.

James W Kaspar1, Suryakant K Niture, Anil K Jaiswal.   

Abstract

Nrf2:INrf2 (Keap1) are cellular sensors of chemical- and radiation-induced oxidative and electrophilic stress. Nrf2 is a nuclear transcription factor that controls the expression and coordinated induction of a battery of defensive genes encoding detoxifying enzymes and antioxidant proteins. This is a mechanism of critical importance for cellular protection and cell survival. Nrf2 is retained in the cytoplasm by an inhibitor, INrf2 which functions as an adapter for Cul3/Rbx1-mediated degradation of Nrf2. In response to oxidative/electrophilic stress, Nrf2 is switched on and then off by distinct early and delayed mechanisms. Oxidative/electrophilic modification of INrf2 cysteine 151 and/or protein kinase C phosphorylation of Nrf2 serine 40 results in the escape or release of Nrf2 from INrf2. Nrf2 is stabilized and translocates to the nucleus, forms heterodimers with unknown proteins, and binds the antioxidant response element, which leads to coordinated activation of gene expression. It takes less than 15 min from the time of exposure to switch on nuclear import of Nrf2. This is followed by activation of a delayed mechanism that controls the switching off of Nrf2 activation of gene expression. GSK3beta phosphorylates Fyn at an unknown threonine residue(s), leading to the nuclear localization of Fyn. Fyn phosphorylates Nrf2 tyrosine 568, resulting in the nuclear export of Nrf2, binding with INrf2, and degradation of Nrf2. The switching on and off of Nrf2 protects cells against free radical damage, prevents apoptosis, and promotes cell survival.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19666107      PMCID: PMC2763938          DOI: 10.1016/j.freeradbiomed.2009.07.035

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  98 in total

Review 1.  The Nrf2-Keap1 defence pathway: role in protection against drug-induced toxicity.

Authors:  Ian M Copple; Christopher E Goldring; Neil R Kitteringham; B Kevin Park
Journal:  Toxicology       Date:  2007-11-12       Impact factor: 4.221

Review 2.  The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration.

Authors:  Jeffrey A Johnson; Delinda A Johnson; Andrew D Kraft; Marcus J Calkins; Rebekah J Jakel; Marcelo R Vargas; Pei-Chun Chen
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 3.  GSK3beta: a master switch and a promising target.

Authors:  Akanksha Kannoji; Samiron Phukan; V Sudher Babu; Vitukudi N Balaji
Journal:  Expert Opin Ther Targets       Date:  2008-11       Impact factor: 6.902

4.  Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.

Authors:  Tatsuhiro Shibata; Akiko Kokubu; Masahiro Gotoh; Hidenori Ojima; Tsutomu Ohta; Masayuki Yamamoto; Setsuo Hirohashi
Journal:  Gastroenterology       Date:  2008-07-03       Impact factor: 22.682

5.  Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal cell death.

Authors:  Ana I Rojo; Patricia Rada; Javier Egea; Angelo O Rosa; Manuela G López; Antonio Cuadrado
Journal:  Mol Cell Neurosci       Date:  2008-06-20       Impact factor: 4.314

6.  Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2.

Authors:  Xiao-Jun Wang; Zheng Sun; Nicole F Villeneuve; Shirley Zhang; Fei Zhao; Yanjie Li; Weimin Chen; Xiaofang Yi; Wenxin Zheng; Georg T Wondrak; Pak Kin Wong; Donna D Zhang
Journal:  Carcinogenesis       Date:  2008-04-15       Impact factor: 4.944

7.  Phosphorylation and dephosphorylation of tyrosine 141 regulate stability and degradation of INrf2: a novel mechanism in Nrf2 activation.

Authors:  Abhinav K Jain; Shilpi Mahajan; Anil K Jaiswal
Journal:  J Biol Chem       Date:  2008-04-23       Impact factor: 5.157

8.  Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth.

Authors:  Tsutomu Ohta; Kumiko Iijima; Mamiko Miyamoto; Izumi Nakahara; Hiroshi Tanaka; Makiko Ohtsuji; Takafumi Suzuki; Akira Kobayashi; Jun Yokota; Tokuki Sakiyama; Tatsuhiro Shibata; Masayuki Yamamoto; Setsuo Hirohashi
Journal:  Cancer Res       Date:  2008-03-01       Impact factor: 12.701

9.  Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy.

Authors:  Tatsuhiro Shibata; Tsutomu Ohta; Kit I Tong; Akiko Kokubu; Reiko Odogawa; Koji Tsuta; Hisao Asamura; Masayuki Yamamoto; Setsuo Hirohashi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

10.  Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid.

Authors:  Jonathan M Maher; Lauren M Aleksunes; Matthew Z Dieter; Yuji Tanaka; Jeffrey M Peters; Jose E Manautou; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2008-08-29       Impact factor: 4.849

View more
  461 in total

1.  MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism.

Authors:  Muhua Yang; Yuan Yao; Gabriel Eades; Yongshu Zhang; Qun Zhou
Journal:  Breast Cancer Res Treat       Date:  2011-06-03       Impact factor: 4.872

2.  Inhibitor of Nrf2 (INrf2 or Keap1) protein degrades Bcl-xL via phosphoglycerate mutase 5 and controls cellular apoptosis.

Authors:  Suryakant K Niture; Anil K Jaiswal
Journal:  J Biol Chem       Date:  2011-11-09       Impact factor: 5.157

3.  Protective Effect of Piceatannol Against Cerebral Ischaemia-Reperfusion Injury Via Regulating Nrf2/HO-1 Pathway In Vivo and Vitro.

Authors:  Lingfeng Wang; Ying Guo; Jiayi Ye; Zeyue Pan; Peihao Hu; Xiaoming Zhong; Fengmei Qiu; Danni Zhang; Zhen Huang
Journal:  Neurochem Res       Date:  2021-05-24       Impact factor: 3.996

4.  Nrf2-regulated phase II enzymes are induced by chronic ambient nanoparticle exposure in young mice with age-related impairments.

Authors:  Hongqiao Zhang; Honglei Liu; Kelvin J A Davies; Constantinos Sioutas; Caleb E Finch; Todd E Morgan; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2012-03-06       Impact factor: 7.376

Review 5.  Roles for the ubiquitin-proteasome pathway in protein quality control and signaling in the retina: implications in the pathogenesis of age-related macular degeneration.

Authors:  Fu Shang; Allen Taylor
Journal:  Mol Aspects Med       Date:  2012-04-10

6.  Induction of heme oxygenase-1 by chamomile protects murine macrophages against oxidative stress.

Authors:  Natarajan Bhaskaran; Sanjeev Shukla; Rajnee Kanwal; Janmejai K Srivastava; Sanjay Gupta
Journal:  Life Sci       Date:  2012-06-05       Impact factor: 5.037

7.  New Insights into the Pathogenesis of Preeclampsia - The Role of Nrf2 Activators and their Potential Therapeutic Impact.

Authors:  N Kweider; C J Wruck; W Rath
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-12       Impact factor: 2.915

8.  Mitigation of ROS insults by Streptomyces secondary metabolites in primary cortical neurons.

Authors:  Marta Leirós; Eva Alonso; Jon A Sanchez; Mostafa E Rateb; Rainer Ebel; Wael E Houssen; Marcel Jaspars; Amparo Alfonso; Luis M Botana
Journal:  ACS Chem Neurosci       Date:  2013-11-19       Impact factor: 4.418

9.  4-methoxychalcone enhances cisplatin-induced oxidative stress and cytotoxicity by inhibiting the Nrf2/ARE-mediated defense mechanism in A549 lung cancer cells.

Authors:  Juhee Lim; Sung Ho Lee; Sera Cho; Ik-Soo Lee; Bok Yun Kang; Hyun Jin Choi
Journal:  Mol Cells       Date:  2013-09-16       Impact factor: 5.034

Review 10.  Role of mitochondrial oxidative stress in hypertension.

Authors:  Sergey I Dikalov; Zoltan Ungvari
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-16       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.